Brain-Gut Axis: Invasive and Noninvasive Vagus Nerve Stimulation, Limitations, and Potential Therapeutic Approaches
Inflammatory Bowel Diseases · 01.03.2024 · 30 (3) · 482-495
DOI: 10.1093/ibd/izad211 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 21.09.2023. Verfasst von Fatemeh Hesampour und 2 weiteren Autor:innen. Beteiligte Einrichtung: Immunology, University of Manitoba, Winnipeg, Canada. Hauptthemen laut MEDLINE: Vagus Nerve Stimulation, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 114 Literaturangaben. Gefördert von: IMAGINE, Canadian Institutes of Health Research and Research Manitoba.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is a chronic relapsing condition with no known etiology and is characterized by disrupted gut homeostasis, chronic inflammation, and ulcerative lesions. Although current treatments can reduce disease activity, IBD frequently recurs once treatments are discontinued, indicating that treatments are ineffective in providing long-term remission. The lack of responsiveness and reluctance of some affected persons to take medications because of potential adverse effects has enhanced the need for novel therapeutic approaches. The vagus nerve (VN) is likely important in the pathogenesis of IBD, considering the decreased activity of the parasympathetic nervous system, especially the VN, and the impaired interaction between the enteric nervous system and central nervous system in patients with IBD. Vagus nerve stimulation (VNS) has demonstrated anti-inflammatory effects in various inflammatory disorders, including IBD, by inhibiting the production of inflammatory cytokines by immune cells. It has been suggested that stimulating the vagus nerve to induce its anti-inflammatory effects may be a potential therapeutic approach for IBD. Noninvasive techniques for VNS have been developed. Considering the importance of VN function in the brain-gut axis, VNS is a promising treatment option for IBD. This review discusses the potential therapeutic advantages and drawbacks of VNS, particularly the use of noninvasive transcutaneous auricular vagus nerve stimulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology, University of Manitoba, Winnipeg, Canada.
- Internal Medicine, University of Manitoba, Winnipeg, Canada.
- Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba, Winnipeg, Canada.
- Children's Hospital Research Institute of Manitoba, Winnipeg, Canada.
ORCID-Profile: Jean-Eric Ghia
Förderung
- IMAGINE
- Canadian Institutes of Health Research and Research Manitoba
Zitieren
APA
Hesampour, F., Bernstein, C. N., & Ghia, J. E. (2024). Brain-Gut Axis: Invasive and Noninvasive Vagus Nerve Stimulation, Limitations, and Potential Therapeutic Approaches. Inflammatory Bowel Diseases, 30(3), 482-495. https://doi.org/10.1093/ibd/izad211
Vancouver
Hesampour F, Bernstein CN, Ghia JE. Brain-Gut Axis: Invasive and Noninvasive Vagus Nerve Stimulation, Limitations, and Potential Therapeutic Approaches. Inflammatory Bowel Diseases. 2024;30(3):482-495. doi:10.1093/ibd/izad211
BibTeX
@article{Hesampour2024,
author = {Hesampour, Fatemeh and Bernstein, Charles N and Ghia, Jean-Eric},
title = {Brain-Gut Axis: Invasive and Noninvasive Vagus Nerve Stimulation, Limitations, and Potential Therapeutic Approaches},
journal = {Inflammatory Bowel Diseases},
year = {2024},
volume = {30},
number = {3},
pages = {482--495},
doi = {10.1093/ibd/izad211}
}
EUVIMED